Parabolic SAR Indicates Bullish US Stocks: $SA $SLP $MLAB

The Market Signal was created as a platform to help investors, if you own (NYSE:SA), (NASDAQ:SLP) or (NASDAQ:MLAB) and want to join the fastest growing community of investors on the web then sign up to the link below. Members get free access to the best investment tools in the world. Start trading like a pro today. This is a limited time offer so click the link below NOW. Free-Report/NOW
(Click link above or copy, paste and hit enter in your browser for your report)

Seabridge Gold Announces Q2 2020 Net Loss Of $4.1 million

(Click link above or copy, paste and hit enter in your browser for your report)

Seabridge Gold Inc. (NYSE:SA) is trading above its Parabolic SAR of $17.42, thus the stock looks bullish. The company has filed its Q2 2020 financial report for the quarter ended June 30, 2020. During the quarter net loss was $4.1 million or 0.06 per share compared to a loss of $2 million or $0.03 per share a year ago. The company invested $4.4 million during the quarter in mineral interest projects and closed an equity financing of $37.1 million.

The company which owns the proposed KSM Mine in British Columbia has asked the province for a two-year emergency extension on its environmental assessment certificate due to the impact of COVID-19.

Simulations Plus Completes $115 Million Underwritten Public Offering

(Click link above or copy, paste and hit enter in your browser for your report)
Simulations Plus, Inc. (NASDAQ:SLP) is also another stock that is trading above its Parabolic SAR of $56.38 and looking bullish. The company has announced the closing it an underwritten public offering of 2.09 million common shares at $55 per share. The offering includes the full exercise of the underwriter's option to buy an additional 272,727 common shares. The gross proceeds of the offering will be around $115 million.

The company also announced that simulations employing the DILIsym(R) software were used as part of the FDA review of ubrogepant safety which has been approved now in the US. The safety of the ubrogepant using DILIsym has been summarized in a publication in Toxicological Sciences.

Mesa Laboratories Enters Collaboration With Tyglar on Critical Validation Products

(Click link above or copy, paste and hit enter in your browser for your report)
Another bullish looking stock is Mesa Laboratories, Inc. (NASDAQ:MLAB) which is trading above its Parabolic SAR of $234.35. The company has announced the signing of a strategic distribution agreement with Tyglar. The agreement will see the companies partner in the market development and growth of critical validation products. Tyglar's MeCo product line helps engineers in validation to attain consistency and sturdiness between validation cycles that are controlled with the reproductive placement of thermocouples and biological indicators with locations difficult to sterilize.

In its fiscal Q1 2021, the company saw its revenue jump 14% to $29,941 with operating income decreasing 41% to $3,198 compared to a year ago. Net income dropped 78% YoY to $1,025 or $0.22 per share. Adjusted operating income was $7,820 or $1.67 per share in the quarter.

Please email or contact us for any edits or errors relating to this stock market news.

If you would like information on using our press release distribution service aimed at helping investors with the best stocks to buy and how to create your own stock portfolio. We cover the US Stock Market, Canadian Stock Market, the Australian Stock Market and other Stock Market news.

We will get back to you within 24 hours.


comtex tracking


Is there a problem with this press release? Contact the source provider Comtex at